NASDAQ:URGN

Urogen Pharma Stock Insider Trading

etoro logo Buy URGN
*Your capital is at risk
$38.56
-1.67 (-4.15%)
At Close: Jul 10, 2026

UroGen Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -2.90. In total, the insiders bought 828.13K and sold 101.93K URGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-2.90
Buy 828.13K shares
Sell 101.93K shares
79% Buy Activity
Strong Negative Correlation
Buy Signal Low Confidence
Jun 22, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date Type Person Role Amount
Jul 09, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 10 000
Value: $400.0K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Belldegrun Arie
Director
Director 20 000
Value: $699.8K
Jun 22, 2026
Buy
Restricted Stock Unit
A-Award
Wen Leana
Director
Director 8 000
Value: $279.9K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Wen Leana
Director
Director 10 000
Value: $349.9K
Jun 22, 2026
Buy
Restricted Stock Unit
A-Award
Robinson James A. Jr.
Director
Director 8 000
Value: $279.9K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Robinson James A. Jr.
Director
Director 10 000
Value: $349.9K
Jun 22, 2026
Buy
Restricted Stock Unit
A-Award
Wildman Daniel George
Director
Director 8 000
Value: $279.9K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Wildman Daniel George
Director
Director 10 000
Value: $349.9K
Jun 22, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 10 000
Value: $350.1K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Holden Stuart
Director
Director 20 000
Value: $699.8K
Jun 22, 2026
Buy
Stock Option (right ot buy)
A-Award
Butitta Cynthia M
Director
Director 10 000
Value: $349.9K
Jun 22, 2026
Buy
Restricted Stock Unit
A-Award
Butitta Cynthia M
Director
Director 8 000
Value: $279.9K
Jun 08, 2026
Buy
Restricted Stock Units
M-Exempt
Schoenberg Mark
Chief Medical Officer
Officer 10 000
Value: $272.5K
Jun 08, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 5 222
Value: $142.6K
Jun 08, 2026
Buy
Ordinary Shares
M-Exempt
Schoenberg Mark
Chief Medical Officer
Officer 10 000
Value: $272.5K
May 26, 2026
Buy
Restricted Stock Unit
M-Exempt
Robinson James A. Jr.
Director
Director 2 000
Value: $58.9K
May 26, 2026
Buy
ordinary shares
M-Exempt
Robinson James A. Jr.
Director
Director 2 000
Value: $58.9K
May 08, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 10 000
Value: $300.0K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Smith Jason Drew
General Counsel
Officer 3 217
Value: $63.3K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Smith Jason Drew
General Counsel
Officer 2 654
Value: $52.3K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Smith Jason Drew
General Counsel
Officer 1 608
Value: $31.7K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 1 844
Value: $36.3K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 1 843
Value: $36.3K
Feb 03, 2026
Sell
Ordinary Shares
S-Sale
Schoenberg Mark
Chief Medical Officer
Officer 3 686
Value: $72.6K
Jan 31, 2026
Buy
Restricted Stock Units
A-Award
Barrett Elizabeth A.
Chief Executive Officer
CEO / President 153 195
Value: $5.91M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UROGEN PHARMA LTD
UroGen Pharma
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE